Long-term survival in a patient with advanced non-smoking lung adenocarcinoma and no EGFR mutation after comprehensive therapy with EGFR-TKI-based therapy: A case report

RATIONALE: This is the first known report to describe a case of advanced non-smoking lung adenocarcinoma with no epidermal growth factor receptor mutation after comprehensive epidermal growth factor receptor-tyrosine kinase inhibitor-based therapy that survived for nearly 12 years. PATIENT CONCERNS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qianyu, Liu, Meiling, Zhong, Yunchao, Zhang, Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757914/
https://www.ncbi.nlm.nih.gov/pubmed/35029237
http://dx.doi.org/10.1097/MD.0000000000028583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757914/
https://www.ncbi.nlm.nih.gov/pubmed/35029237
http://dx.doi.org/10.1097/MD.0000000000028583

Ejemplares similares